• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性队列研究:严重和危重症 COVID-19 患者营养状况与预后的关系。

A retrospective cohort study on the association between nutritional status and prognosis in COVID-19 patients with severe and critical infection.

机构信息

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Nursing Department, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

J Int Med Res. 2024 Nov;52(11):3000605241292326. doi: 10.1177/03000605241292326.

DOI:10.1177/03000605241292326
PMID:39506245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542134/
Abstract

OBJECTIVE

To evaluate the relationship between nutritional scoring systems, nutritional support methods, and the prognosis of severe and critically ill patients infected with the Omicron variant of coronavirus disease 2019 (COVID-19).

METHODS

Patients with confirmed Omicron variant severe and critical COVID-19, who were admitted to Chongqing Medical University First Hospital between December 2022 and January 2023, were enrolled into this retrospective study. Clinical data of patients who survived for 28 days were compared with those who died during the same period. Nutritional status was assessed using the 2002 Nutrition Risk Screening (NRS) tool and Prognostic Nutritional Index (PNI). Factors influencing patient mortality were identified by multivariate logistic regression, and the relationship between patient nutrition and mortality as the disease progressed was illustrated using Kaplan-Meier curves. The study was registered on the ChiCTR platform (No. ChiCTR2300067595).

RESULTS

A total of 508 patients were included (349 survivors and 159 non-survivors). Significant differences were found in sex, age, NRS score, PNI score, albumin level, lymphocyte count, chronic comorbidities, mechanical ventilation, neutrophil count, procalcitonin, and platelet count between survivors and non-survivors. Multivariate analysis revealed that high NRS score (OR 3.87, 95% CI, 1.97, 7.63), fourth-level nutritional support (combined enteral and parenteral nutrition; OR 7.89, 95% CI, 1.32, 47.28), chronic comorbidities (OR 4.03, 95% CI, 1.91, 8.51), and mechanical ventilation (OR 6.03, 95% CI, 3, 12.13) were risk factors for mortality (OR > 1). The malnutrition rate among patients with NRS ≥ 3 was 41.93%. The median (interquartile range) PNI score was 38.20 (35.65, 41.25) for survivors versus 32.65 (29.65, 36.58) for non-survivors. The mortality rate was higher in patients with high nutritional risk within 28 days of hospitalization. The descending order for mortality rate in patients receiving different nutritional support was: dual parenteral and enteral nutrition, no nutritional intervention, single enteral nutrition, and single parenteral nutrition.

CONCLUSION

A high proportion of severe and critically ill patients with COVID-19 experience malnutrition, and various factors are associated with their prognosis. High nutritional risk is significantly related to patient mortality. Early assessment using NRS or PNI is crucial for these patients, and personalized interventions should be implemented to improve overall nutritional status, maintain organ function, and enhance the body's antiviral defence.

摘要

目的

评估营养评分系统、营养支持方法与感染 2019 年冠状病毒病(COVID-19)奥密克戎变异株的重症和危重症患者预后之间的关系。

方法

本回顾性研究纳入 2022 年 12 月至 2023 年 1 月期间重庆医科大学附属第一医院收治的确诊奥密克戎变异株的重症和危重症 COVID-19 患者。比较存活 28 天患者的临床资料与同期死亡患者。采用 2002 年营养风险筛查(NRS)工具和预后营养指数(PNI)评估患者的营养状况。采用多因素 logistic 回归确定影响患者死亡率的因素,并通过 Kaplan-Meier 曲线说明患者营养状况与疾病进展的关系。该研究在 ChiCTR 平台(注册号:ChiCTR2300067595)上注册。

结果

共纳入 508 例患者(349 例存活患者和 159 例非存活患者)。存活患者和非存活患者在性别、年龄、NRS 评分、PNI 评分、白蛋白水平、淋巴细胞计数、慢性合并症、机械通气、中性粒细胞计数、降钙素原和血小板计数方面存在显著差异。多因素分析显示,NRS 评分高(OR 3.87,95%CI,1.97,7.63)、四级营养支持(联合肠内和肠外营养;OR 7.89,95%CI,1.32,47.28)、慢性合并症(OR 4.03,95%CI,1.91,8.51)和机械通气(OR 6.03,95%CI,3,12.13)是死亡的危险因素(OR>1)。NRS≥3 的患者营养不良发生率为 41.93%。存活患者的中位(四分位间距)PNI 评分为 38.20(35.65,41.25),而非存活患者的 PNI 评分为 32.65(29.65,36.58)。住院 28 天内高营养风险患者的死亡率更高。接受不同营养支持的患者死亡率依次为:双肠外和肠内营养、无营养干预、单肠内营养和单肠外营养。

结论

COVID-19 重症和危重症患者营养不良发生率较高,多种因素与患者预后相关。高营养风险与患者死亡率显著相关。早期使用 NRS 或 PNI 评估至关重要,应实施个性化干预措施,改善整体营养状况,维持器官功能,增强机体抗病毒防御能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/01e560f333d8/10.1177_03000605241292326-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/c748de12348f/10.1177_03000605241292326-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/67604f1b29ac/10.1177_03000605241292326-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/01e560f333d8/10.1177_03000605241292326-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/c748de12348f/10.1177_03000605241292326-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/67604f1b29ac/10.1177_03000605241292326-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/11542134/01e560f333d8/10.1177_03000605241292326-fig3.jpg

相似文献

1
A retrospective cohort study on the association between nutritional status and prognosis in COVID-19 patients with severe and critical infection.回顾性队列研究:严重和危重症 COVID-19 患者营养状况与预后的关系。
J Int Med Res. 2024 Nov;52(11):3000605241292326. doi: 10.1177/03000605241292326.
2
Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study.严重和危重新冠肺炎患者的营养风险和治疗:一项多中心回顾性观察研究。
Clin Nutr. 2021 Apr;40(4):2154-2161. doi: 10.1016/j.clnu.2020.09.040. Epub 2020 Oct 1.
3
Nutritional screening based on objective indices at admission predicts in-hospital mortality in patients with COVID-19.入院时基于客观指标的营养筛查可预测 COVID-19 患者的院内死亡率。
Nutr J. 2021 May 25;20(1):46. doi: 10.1186/s12937-021-00702-8.
4
Evaluation of Nutrition Risk and Its Association With Mortality Risk in Severely and Critically Ill COVID-19 Patients.评估严重和危重新冠肺炎患者的营养风险及其与死亡率风险的关系。
JPEN J Parenter Enteral Nutr. 2021 Jan;45(1):32-42. doi: 10.1002/jpen.1953. Epub 2020 Jul 20.
5
Comparison of nutritional risk status assessment tools in predicting 30-day survival in critically ill COVID-19 pneumonia patients.比较营养风险评估工具在预测 COVID-19 肺炎危重症患者 30 天生存率中的应用。
Ann Saudi Med. 2022 Jul-Aug;42(4):236-245. doi: 10.5144/0256-4947.2022.236. Epub 2022 Aug 4.
6
Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.早期肠内营养可改善 COVID-19 重症患者的预后:一项回顾性研究。
Asia Pac J Clin Nutr. 2021 Jun;30(2):192-198. doi: 10.6133/apjcn.202106_30(2).0002.
7
Malnutrition is associated with severe outcome in elderly patients hospitalised with COVID-19.营养不良与因 COVID-19 住院的老年患者的严重结局相关。
Sci Rep. 2024 Oct 17;14(1):24367. doi: 10.1038/s41598-024-76363-4.
8
High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes.2019年冠状病毒病(COVID-19)住院患者中营养不良的高风险与死亡率及其他临床结局相关。
Clin Nutr ESPEN. 2024 Jun;61:1-7. doi: 10.1016/j.clnesp.2024.02.023. Epub 2024 Mar 4.
9
Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19.预后营养指数作为 COVID-19 患者免疫营养状况的指标。
Int J Vitam Nutr Res. 2022 Jan;92(1):4-12. doi: 10.1024/0300-9831/a000730. Epub 2021 Sep 20.
10
The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.改良的 NUTRIC 评分可用于危重症 COVID-19 患者的营养风险评估和预后预测。
Clin Nutr. 2021 Feb;40(2):534-541. doi: 10.1016/j.clnu.2020.05.051. Epub 2020 Jun 5.

引用本文的文献

1
The Duration of Prophylactic Antibiotic Use for Esophageal Cancer Patients with Postoperative Infection and Nutritional Status.食管癌术后感染患者预防性使用抗生素的持续时间与营养状况
Int J Gen Med. 2025 Aug 5;18:4267-4277. doi: 10.2147/IJGM.S513707. eCollection 2025.

本文引用的文献

1
Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing.炎症衰老:细胞因子与营养如何塑造衰老轨迹。
Cytokine Growth Factor Rev. 2025 Apr;82:31-42. doi: 10.1016/j.cytogfr.2024.08.004. Epub 2024 Sep 2.
2
Improving geriatric outcomes through nutritional and immunonutritional strategies: Focus on surgical setting by a comprehensive evidence review.通过营养和免疫营养策略改善老年患者结局:通过全面证据回顾聚焦手术环境。
Ageing Res Rev. 2024 Apr;96:102272. doi: 10.1016/j.arr.2024.102272. Epub 2024 Mar 15.
3
The role of nutritional risk evaluation in predicting adverse outcomes among patients with severe COVID-19 in Vietnam.
营养风险评估在预测越南重症新型冠状病毒肺炎患者不良结局中的作用。
Front Nutr. 2023 Oct 5;10:1245816. doi: 10.3389/fnut.2023.1245816. eCollection 2023.
4
Identifying malnutrition in emergency general surgery: systematic review.识别急诊普通外科中的营养不良:系统评价。
BJS Open. 2023 Sep 5;7(5). doi: 10.1093/bjsopen/zrad086.
5
Inflammation and malnutrition in inflammatory bowel disease.炎症性肠病中的炎症和营养不良。
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):579-590. doi: 10.1016/S2468-1253(23)00011-0. Epub 2023 Mar 15.
6
Prognostic Nutritional Index as a Predictor of Mortality in 101,616 Patients Undergoing Hemodialysis.预后营养指数作为 101616 例行血液透析患者死亡率的预测指标。
Nutrients. 2023 Jan 8;15(2):311. doi: 10.3390/nu15020311.
7
The use of prognostic nutritional index (PNI) and selected inflammatory indicators for predicting malnutrition in COVID-19 patients: A retrospective study.运用预后营养指数(PNI)和特定炎症指标预测 COVID-19 患者的营养不良:一项回顾性研究。
J Infect Public Health. 2023 Feb;16(2):280-285. doi: 10.1016/j.jiph.2022.12.018. Epub 2022 Dec 30.
8
A Synergistic Association Between Inflammation, Malnutrition, and Mortality in Patients With Diabetics.糖尿病患者炎症、营养不良与死亡率之间的协同关联
Front Nutr. 2022 Jun 2;9:872512. doi: 10.3389/fnut.2022.872512. eCollection 2022.
9
Nutritional Risk Assessment Scores Effectively Predict Mortality in Critically Ill Patients with Severe COVID-19.营养风险评估评分可有效预测重症 COVID-19 患者的死亡率。
Nutrients. 2022 May 18;14(10):2105. doi: 10.3390/nu14102105.
10
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.腺病毒 5 型载体疫苗和灭活 COVID-19 疫苗对由 B.1.617.2(德尔塔)变异株引起的有症状 COVID-19、COVID-19 肺炎和重症 COVID-19 的有效性:来自中国云南 2021 年暴发疫情的证据。
Vaccine. 2022 May 3;40(20):2869-2874. doi: 10.1016/j.vaccine.2022.03.067. Epub 2022 Apr 1.